Episodios

  • The Intersection of Dry Eye and Allergies
    Apr 2 2026
    Co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, invite Mila Ioussifova, OD, CNS, FAAO, FOWNS, back on the To the Point podcast to talk about in-office allergy testing. Dr. Ioussifova has built her dry eye and ocular allergy treatment armamentarium over the course of 13 years in practice. She notes that combined, dry eye and ocular allergy can be part of a vicious cycle if the underlying dysregulated immune system isn’t addressed—this is where immunotherapy comes in. Dr. Ioussifova covers her in-office pretesting protocol and the billing and reimbursement behind it.
    Más Menos
    33 m
  • Continuing the Dry Eye Conversation
    Jan 13 2026
    Kicking off the first episode of the To the Point podcast in 2026, co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, continue the dry eye conversation with DED pearls to implement in clinic. They cover everything from patient signs, symptoms, and side effects to in-office tools, treatments, and therapeutics and OTC options.
    Más Menos
    37 m
  • A Year of Dry Eye Innovation
    Dec 18 2025
    In the final 2025 episode of the To the Point podcast, co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, take a moment to look back on the innovations, learnings, and FDA approvals in ocular surface disease over the past year. They also share their vision for dry eye management in 2026, including advances they’re looking forward to and goals they plan to implement in their practices.
    Más Menos
    25 m
  • Clinical Pearls for Autologous Serum Drops
    Nov 12 2025
    Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, welcome Alfonso L. Sabater, MD, PhD, on this episode of To the Point to share his expertise on the use of autologous serum drops in the treatment of ocular surface and corneal disease. Dr. Sabater describes some of the clinical benefits and challenges, which patients may be ideal candidates, and what clinicians should know when getting started with this treatment option.
    Más Menos
    31 m
  • Aesthetics and the Ocular Surface
    Oct 24 2025
    Tracy Doll, OD, FAAO, joins co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, on this episode of To the Point to share her expertise with the aesthetics side of managing ocular surface disease. Dr. Doll discusses her experiences addressing patients’ clinical and aesthetic concerns, educating patients and other providers on the cosmetic benefits of certain dry eye therapies, integrating new innovations in her clinic, and more.
    Más Menos
    29 m
  • Running a Standalone Dry Eye Clinic
    Sep 10 2025
    To the Point co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, sit down with Jason Besecker, OD, MS, to get his perspective on opening a dry eye only clinic. Dr. Besecker shares how he became interested in treating dry eye patients exclusively, growing his referral base after opening his practice, maintaining profitability without an optical shop, technology and diagnostics he has incorporated over the years, and more.
    Más Menos
    34 m
  • Building Out a Dry Eye and Aesthetics Practice
    Aug 13 2025
    This month on To the Point, Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, invite Shane Swatts, OD, to join them on the podcast to share tips from his experience growing a dry eye and ocular aesthetics practice. He talks about integrating cutting-edge technology, gives advice on discussing advanced treatment options with patients, suggests how to set actionable treatment goals, and more.
    Más Menos
    45 m
  • Takeways From the TFOS DEWS III Report
    Jul 8 2025
    In this episode of To the Point, Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, get into a deep discussion with Vin T. Dang, OD, FAAO, on the recent Tear Film & Ocular Surface Society Dry Eye Workshop (TFOS DEWS) III Report. Dr. Dang shares his top takesaways from the report and offers his thoughts on a recently FDA-approved neuromodulating agent that treats dry eye by stimulating increased tear production.
    Más Menos
    30 m